Vancouver, BC – Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced it has received pre-market approval (PMA) for the Globe® Pulsed Field… Read More
VANCOUVER, BC – Zymeworks Inc. a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and… Read More
Positive results were observed across all subgroups Study meets several key secondary endpoints with statistical significance SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. – United Therapeutics Corporation, a public benefit… Read More
Vabysmo now covered across all three approved indications in the province, providing patients with a single, comprehensively funded solution MISSISSAUGA, ON- Hoffmann-La Roche Limited (Roche Canada) is pleased to announce… Read More
Selective APRIL inhibition has shown disease-modifying potential in IgAN patient clinical trials JADE101 has shown ultra-high binding affinity and a differentiated pharmacokinetic and pharmacodynamic profile preclinically, supporting the potential for… Read More
